Evolutionary Genomics (FNAM) Stock Price

Evolutionary Genomics Price

NYSE·CLOSED
0.00
​
Market closed

Revenue at Evolutionary Genomics has contracted by 42.6% per year over the past 6 years to 12,500.00 USD. For Evolutionary Genomics, the net margin of -15,980.0% is down versus -608.6% a few years ago.

Evolutionary Genomics stock price

Access this data via the Eulerpool API

Evolutionary Genomics business model & stock analysis

Evolutionary Genomics, Inc. is a genomics research and development company, which engages in the identification and validation of genes. The company is headquartered in Castle Rock, Colorado and currently employs 2 full-time employees. The company went IPO on 2011-03-03. The firm is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. The company uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The firm has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.

Frequently asked questions about Evolutionary Genomics

Converted at the current exchange rate, the Evolutionary Genomics share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Evolutionary Genomics.

The profit cannot currently be calculated for Evolutionary Genomics.

The P/E ratio cannot be calculated for Evolutionary Genomics at the moment.

The P/S cannot be calculated for Evolutionary Genomics currently.

The Eulerpool Quality Score for Evolutionary Genomics is 2/10.

The ISIN of Evolutionary Genomics is US30051F1012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Evolutionary Genomics is FNAM. The ticker symbol is used to trade Evolutionary Genomics shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website evolgen.com
Currency
USD
Initial public offering
Mar 3, 2011
ISIN
US30051F1012
Cusip
30051F101
Market capitalization
1,332.00 USDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-103.35 %
Gross Margin
—
EBIT Margin
—
Net Margin
—
EPS (Earnings Per Share)
-0.35 USD
Net Debt / EBIT
-1.86
Debt/Equity
-2.39
Last updated Sep 30, 2026, 9:00 PM

Evolutionary Genomics Peer Group

Evolutionary Genomics Ticker

OTC · FNAM

Evolutionary Genomics FIGI

FNAM:US · BBG001KBVLT8FNAM:PQ · BBG001KBVM70FNAM:UV · BBG001KBVM98